Steckelings U M, Kaschina E, Unger Th
Center for Cardiovascular Research, Institut für Pharmakologie und Toxikologie, Charité-Universitätsmedizin Berlin, Hessische Strasse 3-4, 10115 Berlin, Germany.
Peptides. 2005 Aug;26(8):1401-9. doi: 10.1016/j.peptides.2005.03.010. Epub 2005 Apr 18.
In 1989, the development of specific angiotensin receptor antagonists which distinguish between two angiotensin receptor subtypes (AT1 and AT2) led to a breakthrough in angiotensin research. It turned out, that the AT1 receptor was almost entirely responsible for the "classical" actions of angiotensin II related to the regulation of blood pressure as well as volume and electrolyte balance. However, actions and signal transduction mechanisms coupled to the AT2 receptor remained enigmatic for a long time. The present review summarizes the current knowledge of AT2 receptor distribution, signaling and function with an emphasis on growth/anti-growth, differentiation and the regeneration of neuronal tissue.
1989年,能够区分两种血管紧张素受体亚型(AT1和AT2)的特异性血管紧张素受体拮抗剂的研制取得了突破,这在血管紧张素研究领域引发了变革。结果表明,AT1受体几乎完全介导了血管紧张素II在调节血压、血容量及电解质平衡方面的“经典”作用。然而,与AT2受体相关的作用及信号转导机制长期以来一直扑朔迷离。本综述总结了目前关于AT2受体分布、信号转导及功能的知识,重点关注其在生长/抗生长、分化及神经组织再生方面的作用。